SEAMUS WINTERS: Open Payments
NPI 1497309850 · HORSHAM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 21 payments from 10 companies in 2025. Trend: 2023 $382 · 2024 $548 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $248 |
| CVRx, Inc. | 1 | $151 |
| BridgeBio Pharma, Inc. | 1 | $127 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| Amgen Inc. | 2 | $37 |
| Boston Scientific Corporation | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| PFIZER INC. | 1 | $16 |
Products named: Barostim Neo System, CAMZYOS, Attruby, REPATHA, ELIQUIS, WATCHMAN Access System, CAPVAXIVE, ONPATTRO.
Industry payments across PA — which companies pay providers there.
